Showing 5,441 - 5,460 results of 40,274 for search '"Management"', query time: 0.12s Refine Results
  1. 5441
  2. 5442

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    “…Convalescent plasma is rich with cytokines (IL-1β, IL-2, IL-6, IL-17, and IL-8), CCL2, and TNFα, neutralizing antibodies, and clotting factors essential for the management of SARS-CoV-2 infection. Clinical trials can inform and guide treatment policy, leading to mainstream adoption of convalescent therapy. …”
    Get full text
    Article
  3. 5443

    Employee Rewards Management and the Performance of Small Scale Enterprises in Uganda, a Case of Ntungamo Municipality by Moses, Agaba, Turyasingura, John Bosco, Kyabarongo, Benon

    Published 2022
    “…The study investigated the effects of reward management methods on the performance of small businesses in the industrial and service sectors in Ntungamo Municipality. …”
    Get full text
    Article
  4. 5444

    Effects of Management Factors on Project Implementation in Government Aided Secondary Schools in Kabale District, Uganda by Moses, Agaba, Turyasingura, John Bosco

    Published 2022
    Subjects: “…Management Factors,Project Implementation, Government-aided schools, Kabale, Uganda…”
    Get full text
    Article
  5. 5445
  6. 5446

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Mohamed, Moubarak, Keneth Iceland, Kasozi, Helal F., Hetta, Hazem M., Shaheen, Abdur, Rauf, Hayder M., Al-kuraishy, Safaa, Qusti, Eida M., Alshammari, Emmanuel Tiyo, Ayikobua, Fred, Ssempijja, Adam Moyosore, Afodun, Ritah, Kenganzi, Ibe Michael, Usman, Juma John, Ochieng, Lawrence Obado, Osuwat, Kevin, Matama, Ali I., Al-Gareeb, Emmanuel, Kairania, Monica, Musenero, Susan, Christina Welburn, Gaber, El-Saber Batiha

    Published 2023
    “…Convalescent plasma is rich with cytokines (IL-1β, IL-2, IL-6, IL-17, and IL-8), CCL2, and TNFα, neutralizing antibodies, and clotting factors essential for the management of SARS-CoV-2 infection. Clinical trials can inform and guide treatment policy, leading to mainstream adoption of convalescent therapy. …”
    Get full text
    Article
  7. 5447
  8. 5448
  9. 5449
  10. 5450
  11. 5451
  12. 5452
  13. 5453
  14. 5454
  15. 5455
  16. 5456
  17. 5457
  18. 5458
  19. 5459
  20. 5460